News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Company News

Cardinal Health Launches New Antimicrobial Stewardship Program
Hospitals Seek Compliance with New Antimicrobial Stewardship Requirements Coming in 2017
Antimicrobial stewardship case study
A 15 hospital health system in central United States improved compliance and patient care while reducing drug costs with the Cardinal Health Antimicrobial Stewardship solution.

DUBLIN, Ohio, July 15, 2016 — With new Antimicrobial Stewardship requirements announced for implementation in 2017, Cardinal Health launched its Antimicrobial Stewardship Program.  The program will help hospitals focus on the seven core elements of antimicrobial stewardship – the principle component of these new requirements. It is designed to help hospitals become compliant with the new requirements while optimizing antibiotic use and combating antibiotic resistance.

“The changing healthcare environment is complex, and hospital decision makers are looking for guidance in Antimicrobial Stewardship requirements,” said Kathy Chase, product leader in Drug Cost Control Solutions at Cardinal Health “We’ve heard this repeatedly from customers as they navigate the new requirements coming in January 2017, and we’re proud to offer a program that meets the needs of our community and helps them achieve optimal clinical outcomes related to antimicrobial use.”

According to the Centers for Disease Control, nearly 23,000 deaths occur annually as a result of 2 million people sickened by antibiotic-resistant infections, and up to 50 percent of antibiotic use in hospitals is inappropriate. To combat these outcomes, Cardinal Health is offering a three-tiered approach to Antimicrobial Stewardship:

  1. Assessment: The program begins with analyzing hospitals’ current processes, determining if the core elements of stewardship and the related new requirements are being met, and recommending how to close gaps.
  2. Implementation: Necessary steps are implemented to realize the impact of the core elements of stewardship and move hospitals toward compliance.  This includes educating hospital staff. This is a customized process, designed to align with hospitals’ resource capabilities.
  3. Antimicrobial Analytics: Because antibiotic analytics are a key element of the new requirements, the final step is to trend antibiotic selection and use over time and benchmark to other hospitals; compare “drug vs. bug” to evaluate susceptibility and resistance patterns and determine best agent for the hospital population. This allows hospitals to drill into DRG and prescribing physician information.

Recent case studies of Cardinal Health’s Antimicrobial Stewardship Program show dramatic results from hospital systems of various sizes, including a 20 to 40 percent recorded reduction in antimicrobial costs and up to 50 percent reduction in selected antimicrobial drug spending. Comprehensive programs have demonstrated a 22 to 36 percent decrease in antimicrobial use, resulting in an annual savings of $200,000 to $900,000.

For more information on Cardinal Health’s Antimicrobial Stewardship program, visit

About Cardinal Health 
Cardinal Health, Inc. (NYSE: CAH), a global health services and products company, brings scaled solutions that help our customers thrive in a changing world. We improve the cost-effectiveness of healthcare through solutions that improve the efficiency of the supply chain; optimize the process and performance of healthcare; provide clinically proven, daily use medical products and pharmaceuticals; and connect patients, providers, payers, pharmacists and manufacturers for seamless care coordination and better patient management. Backed by nearly 100 years of experience, we rank among the top 50 on the Fortune 500 and among the Fortune Global 100.  We support our partners with more than 37,000 employees in nearly 60 countries worldwide. For more information, visit and @CardinalHealth on Twitter.

For further information: Courtney Tobin (614) 757-5539
More Company News

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health


Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...


Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields